Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > ARCHIVE
ARCHIVE
- Rate of Generic Drug Use Declined in February, March: Survey
July 25, 2011
- Korosho to Promote Anti-HTLV-1 Measures
July 25, 2011
- Director Yoshida Warns Pharmacies about Gov't Taking Harsh Stance on Dispensing Fees
July 25, 2011
- 85% of Doctors Uneasy about Prescribing Generics: MedPeer Survey
July 25, 2011
- State Subsidy Recommended for MSD's HPV Vaccine Gardasil
July 25, 2011
- LDP Subcommittee Holds Hearing on Unification of Dispensing Fees
July 25, 2011
- “Biosimilars Era”Coming to Japan: Mr Sawai of JGA
July 25, 2011
- JPA to Collect ADR Avoidance Case Reports from Pharmacies
July 25, 2011
- Merck Serono to Enter 2nd High Growth Stage after Stable Growth in 2011-2012: President Smith
July 25, 2011
- No Major Obstacle to Japan's Participation in PIC/S: Chairman Graberg
July 25, 2011
- Teva Obtains All Shares from Taiyo Pharm. for ¥74 Bil.
July 25, 2011
- APEX to Build Up Nationwide Network
July 25, 2011
- Drug Production in March Down as Much as 65% in 3 Quake-hit Prefectures: Korosho
July 25, 2011
- Rivaroxaban Approved for Prevention of DVT in the US
July 25, 2011
- HPB Issues Notification Aimed at Increasing Efficiency of Clinical Trials
July 25, 2011
- J-CKDI Predicts Dialysis Patients to Decrease after Peak in 2017
July 25, 2011
- BMKK to Take the Offensive with 1st-line CML Treatment Sprycel
July 25, 2011
- Combinational Use of Avastin, Xeloda Approved in Europe: Roche
July 25, 2011
- Tohoku Univ. to Start Clinical Trial for ALS Drug in Japan
July 25, 2011
- Over 11,000 Users Now Registered at Daiichi Sankyo's “Handheld Mother-Child Notebook”Website
July 25, 2011
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…